Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actions

By Wanaka K.   Okamoto S.   Horie N.   Hijikata-Okunomiya A.   Okamoto U.   Naito T.   Ohno N.   Bohgaki M.   Tsuda Y.   Okada Y.  

Thrombosis Research, Vol. 82, Iss. 1, 1996-04 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

Protein Z deficiency: a new cause of bleeding tendency

By Kemtes-Matthes B.   Matthes K.J.  

Thrombosis Research, Vol. 79, Iss. 1, 1995-07 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

2 -Plasmin Inhibitor is a Substrate for Tissue Transglutaminase - An in Vitro Study

By Hevessy Z.   Patthy A.   Karpati L.   Muszbek L.  

Thrombosis Research, Vol. 99, Iss. 4, 2000-08 ,pp. : 399-406

Elsevier

Access to resources Recommend Favorite

Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells

By Guey-Yueh S.   Shwu-Jyh W.   Chi-Fong T.   Ming T.L.   Hua-Lin W.   Bi-Ing C.   Wen-Chang C.   Lih-Yuh C.W.   Chauyin J.J.  

Thrombosis Research, Vol. 81, Iss. 1, 1996-01 ,pp. : 75-84

Elsevier

Access to resources Recommend Favorite

Computer model of the interaction of human TFPI-2 Kunitz-type serine protease inhibitor with human plasmin

By Hube F.   Reverdiau P.   Iochmann S.   Gruel Y.  

Thrombosis Research, Vol. 111, Iss. 3, 2003-01 ,pp. : 197-198

Elsevier

Access to resources Recommend Favorite